Prevalence of Hepatitis B Associated Chronic Nephropathy in Baghdad, Iraq for the Year 2023
Main Article Content
Keywords
Hepatitis B, chronic kidney disease, HBV-associated nephropathy, proteinuria, eGFR
Abstract
Background: The correlation between hepatitis B virus (HBV) and nephropathy presents a significant public health issue in Iraq. Aim: This study systematically investigates the association between hepatitis B surface antigen (HBsAg) serology and chronic kidney disease among residents of Baghdad, Iraq. Methods: We evaluated the clinical characteristics and serologic profiles of 609 patients with adult-onset HBV-related membranous nephropathy. Results: Individuals who are HBsAg (+) have a slightly increased risk of developing eGFR < 60 ml/min/1.73m2 or proteinuria compared to HBsAg (-) individuals. Conclusion: The study emphasizes the substantial impact of HBV on chronic kidney disease, independent of viral replication or inflammation. The findings underscore the importance of understanding the epidemiology and clinical implications of HBV infection in the context of renal complications, revealing potential immunological and pathological mechanisms. Further studies are recommended to elucidate the complex relationship between HBV infection and kidney impairment.
References
2. Sant’Anna TB, Araujo NM. Hepatitis B virus genotype D: an overview of molecular epidemiology, evolutionary history, and clinical characteristics. Microorganisms. 2023;11(5):1101. doi:10.3390/microorganisms11051101
3. Mojiri A, Khadang B, Moaddeb A, et al. Hepatitis B virus genotypes in southwest Iran: molecular, serological and clinical outcomes. World J Gastroenterol. 2008;14(10):1510–3.
4. Khalid FK, Rasheed NA, Hussein NR, Naqid IA. A study of HBV infection and its risk factors in pregnant women in Zakho City, Iraq. PLoS One. 2022;17(8):e0273362. doi:10.1371/journal.pone.0273362
5. Al-Rubaye A, Ziad T, Alrubaiy L. Prevalence of hepatitis B seromarkers and hepatitis C antibodies in blood donors in Basra, Iraq. BMJ Open Gastroenterol. 2016;3(1):e000067. doi:10.1136/bmjgast-2015-000067
6. Ataallah TM, Hanan KA, Maysoun KS, Sadoon AA. Prevalence of hepatitis B and C among blood donors attending the National Blood Transfusion Center in Baghdad, Iraq from 2006–2009. Saudi Med J. 2011;32(10):1046–50.
7. Abdulla IM, Goreal AA. Detection of hepatitis B virus genotypes among chronic carriers in Duhok, Iraq. J Fac Med Baghdad. 2016;58(2):170–5. doi:10.32007/jfacmedbagdad.582234
8. Al-Suraifi ASK, Al-Rubaie ADJ, Al-Mayahie SMG, Al-Abedy NMM. Unusual HBV mixed genotype infections among hepatitis B Iraqi patients in Wasit Province, Iraq. Int J Biomed Eng Clin Sci. 2016;2(1):1. doi:10.11648/j.ijbecs.20160201.11
9. Lai AYK, Lai KN. Viral nephropathy. Nat Clin Pract Nephrol. 2006;2(5):254–62. doi:10.1038/ncpneph0166
10. Khaira A, Upadhyay BK, Sharma A, et al. Hepatitis B virus–associated focal segmental glomerulosclerosis: report of two cases and review of the literature. Clin Exp Nephrol. 2009;13(4):373–7. doi:10.1007/s10157-008-0124-8
11. Ramadhan AA. Prevalence of hepatitis B and hepatitis C virus infections at premarital screening program in Duhok, Iraq. Duhok Med J. 2018;12(1):13–23. doi:10.31386/dmj.uod.18.12.1.2
12. Fabrizi F, Verdesca S, Messa P, Martin P. Hepatitis B virus infection and the development of chronic kidney disease: a meta-analysis. Dig Dis Sci. 2018;63(2):385–96. doi:10.1007/s10620-017-4885-9
13. Zhao JF, Teng QP, Lv Y, et al. Association between hepatitis B or hepatitis C virus infection and risk of pancreatic cancer: a systematic review and meta-analysis of cohort studies. Ther Adv Infect Dis. 2023;10:20499361231212161. doi:10.1177/20499361231212161
14. Cai QC, Zhao SQ, Shi TD, Ren H. Relationship between hepatitis B virus infection and chronic kidney disease in Asian populations: a meta-analysis. Ren Fail. 2016;38(10):1581–8. doi:10.1080/0886022X.2016.1229548
15. Si J, Yu C, Guo Y, et al. Chronic hepatitis B virus infection and risk of chronic kidney disease: a population-based prospective cohort study of 0.5 million Chinese adults. BMC Med. 2018;16:93. doi:10.1186/s12916-018-1084-9
16. Du Y, Zhang S, Hu M, et al. Association between hepatitis B virus infection and chronic kidney disease: a cross-sectional study from 3 million population aged 20–49 years in rural China. Medicine (Baltimore). 2019;98(5):e14262. doi:10.1097/MD.0000000000014262
17. Trépo C, Chan HL, Lok A. Hepatitis B virus infection. Lancet. 2014;384(9959):2053–63. doi:10.1016/S0140-6736(14)60220-8
18. MacLachlan JH, Cowie BC. Hepatitis B virus epidemiology. Cold Spring Harb Perspect Med. 2015;5(5):a021410. doi:10.1101/cshperspect.a021410
19. Deng CL, Song XW, Liang HJ, et al. Chronic hepatitis B serum promotes apoptotic damage in human renal tubular cells. World J Gastroenterol. 2006;12(11):1752–6. doi:10.3748/wjg.v12.i11.1752
20. Chacko EC, Surrun SK, Mubarack Sani TP, Pappachan JM. Chronic viral hepatitis and chronic kidney disease. Postgrad Med J. 2010;86(1018):486–92. doi:10.1136/pgmj.2009.092775
21. Duygu F, Karsen H, Aksoy N, Taskin A. Relationship of oxidative stress in hepatitis B infection activity with HBV DNA and fibrosis. Ann Lab Med. 2012;32(2):113–8. doi:10.3343/alm.2012.32.2.113
22. Chen YC, Su YC, Li CY, et al. Thirteen-year nationwide cohort study of chronic kidney disease risk among treatment-naïve patients with chronic hepatitis B in Taiwan. BMC Nephrol. 2015;16:110. doi:10.1186/s12882-015-0106-5
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Adam Dawoud Salem, Blue Nile National Institute for Communicable Diseases, University of Gezira, Sudan.